These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22215291)

  • 1. Passive transdermal systems whitepaper incorporating current chemistry, manufacturing and controls (CMC) development principles.
    Van Buskirk GA; Arsulowicz D; Basu P; Block L; Cai B; Cleary GW; Ghosh T; González MA; Kanios D; Marques M; Noonan PK; Ocheltree T; Schwarz P; Shah V; Spencer TS; Tavares L; Ulman K; Uppoor R; Yeoh T
    AAPS PharmSciTech; 2012 Mar; 13(1):218-30. PubMed ID: 22215291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Best practices for the development, scale-up, and post-approval change control of IR and MR dosage forms in the current quality-by-design paradigm.
    Van Buskirk GA; Asotra S; Balducci C; Basu P; DiDonato G; Dorantes A; Eickhoff WM; Ghosh T; González MA; Henry T; Howard M; Kamm J; Laurenz S; MacKenzie R; Mannion R; Noonan PK; Ocheltree T; Pai U; Poska RP; Putnam ML; Raghavan RR; Ruegger C; Sánchez E; Shah VP; Shao ZJ; Somma R; Tammara V; Thombre AG; Thompson B; Timko RJ; Upadrashta S; Vaithiyalingam S;
    AAPS PharmSciTech; 2014 Jun; 15(3):665-93. PubMed ID: 24578237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemistry, manufacturing and controls in passive transdermal drug delivery systems.
    Goswami T; Audett J
    Ther Deliv; 2015; 6(9):1071-9. PubMed ID: 26389777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Special Focus Issue: Transdermal, Topical and Folicular Drug Delivery Systems.
    McConville J
    Drug Dev Ind Pharm; 2016; 42(6):845. PubMed ID: 27031915
    [No Abstract]   [Full Text] [Related]  

  • 5. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transdermal revolution.
    Thomas BJ; Finnin BC
    Drug Discov Today; 2004 Aug; 9(16):697-703. PubMed ID: 15341783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the future of heated transdermal delivery systems?
    Otto DP; de Villiers MM
    Ther Deliv; 2014; 5(9):961-4. PubMed ID: 25375338
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemical Penetration Enhancers for Transdermal Drug Delivery - Success and Challenges.
    Ita KB
    Curr Drug Deliv; 2015; 12(6):645-51. PubMed ID: 26239423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An industrial approach towards solid dosage development for first-in-human studies: Application of predictive science and lean principles.
    Kalaria DR; Parker K; Reynolds GK; Laru J
    Drug Discov Today; 2020 Mar; 25(3):505-518. PubMed ID: 31926318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ask the experts: transdermal drug delivery.
    Ther Deliv; 2013 Oct; 4(10):1235-8. PubMed ID: 24116908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and Delivery of Macromolecules.
    Morales JO
    AAPS PharmSciTech; 2017 Jan; 18(1):1-2. PubMed ID: 27943123
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
    Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
    J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turning theory into practice: the development of modern transdermal drug delivery systems and future trends.
    Perumal O; Murthy SN; Kalia YN
    Skin Pharmacol Physiol; 2013; 26(4-6):331-42. PubMed ID: 23921120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies.
    Schenck L; Erdemir D; Saunders Gorka L; Merritt JM; Marziano I; Ho R; Lee M; Bullard J; Boukerche M; Ferguson S; Florence AJ; Khan SA; Sun CC
    Mol Pharm; 2020 Jul; 17(7):2232-2244. PubMed ID: 32392068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raman spectroscopy in pharmaceutical product design.
    Paudel A; Raijada D; Rantanen J
    Adv Drug Deliv Rev; 2015 Jul; 89():3-20. PubMed ID: 25868453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in transdermal drug delivery.
    Subedi RK; Oh SY; Chun MK; Choi HK
    Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Navigating sticky areas in transdermal product development.
    Strasinger C; Raney SG; Tran DC; Ghosh P; Newman B; Bashaw ED; Ghosh T; Shukla CG
    J Control Release; 2016 Jul; 233():1-9. PubMed ID: 27117457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of in vitro dissolution/release methods for novel mucosal drug delivery systems.
    Jug M; Hafner A; Lovrić J; Kregar ML; Pepić I; Vanić Ž; Cetina-Čižmek B; Filipović-Grčić J
    J Pharm Biomed Anal; 2018 Jan; 147():350-366. PubMed ID: 28720350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.